![Anthony William Tolcher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anthony William Tolcher
Fundador en South Texas Accelerated Research Therapeutics LLC .
Cargos activos de Anthony William Tolcher
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
South Texas Accelerated Research Therapeutics LLC
![]() South Texas Accelerated Research Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services South Texas Accelerated Research Therapeutics LLC is a global phase research organization focused on accelerating the development of new anticancer drugs with the purpose of improving life and survival of patients with cancer. The company was founded by Anthony W. Tolcher, Amita Patnaik and Kyriakos P. Papadopoulos and is headquartered in San Antonio, TX. | Fundador | 01/01/2007 | - |
Presidente | 01/01/2007 | - | |
Corporate Officer/Principal | 01/01/2007 | 01/01/2007 |
Historial de carrera de Anthony William Tolcher
Antiguos cargos conocidos de Anthony William Tolcher.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
American Association of Clinical Oncology | Presidente | - | - |
Bristol-Myers Squibb FCT bêta, Inc.
![]() Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Director/Miembro de la Junta | 19/05/2017 | - |
Symphogen A/S
![]() Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Director/Miembro de la Junta | - | - |
Estadísticas
Internacional
Estados Unidos | 3 |
Dinamarca | 2 |
Canadá | 2 |
Operativa
Director/Board Member | 2 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Symphogen A/S
![]() Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Health Technology |
South Texas Accelerated Research Therapeutics LLC
![]() South Texas Accelerated Research Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services South Texas Accelerated Research Therapeutics LLC is a global phase research organization focused on accelerating the development of new anticancer drugs with the purpose of improving life and survival of patients with cancer. The company was founded by Anthony W. Tolcher, Amita Patnaik and Kyriakos P. Papadopoulos and is headquartered in San Antonio, TX. | Commercial Services |
American Association of Clinical Oncology | |
Bristol-Myers Squibb FCT bêta, Inc.
![]() Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Health Technology |